2023 Q4 Form 10-Q Financial Statement

#000079929223000120 Filed on October 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $972.6M $1.046B
YoY Change -20.08% 3.3%
Cost Of Revenue $728.2M $764.6M
YoY Change -22.73% 3.19%
Gross Profit $244.4M $281.7M
YoY Change -10.98% 3.61%
Gross Profit Margin 25.13% 26.92%
Selling, General & Admin $114.5M $109.6M
YoY Change 3.99% 4.76%
% of Gross Profit 46.87% 38.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.594M $3.600M
YoY Change -3.26% -2.86%
% of Gross Profit 1.47% 1.28%
Operating Expenses $114.5M $109.6M
YoY Change 3.99% 4.76%
Operating Profit $129.8M $172.1M
YoY Change -21.01% 2.89%
Interest Expense $8.128M $5.800M
YoY Change -4246.94% 727.39%
% of Operating Profit 6.26% 3.37%
Other Income/Expense, Net
YoY Change
Pretax Income $138.0M $178.0M
YoY Change -15.97% 6.82%
Income Tax $32.69M $38.90M
% Of Pretax Income 23.69% 21.86%
Net Earnings $105.3M $139.0M
YoY Change -19.26% 5.64%
Net Earnings / Revenue 10.82% 13.29%
Basic Earnings Per Share $4.98
Diluted Earnings Per Share $3.66 $4.82
COMMON SHARES
Basic Shares Outstanding 27.85M shares 27.80M shares
Diluted Shares Outstanding 28.84M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $732.8M $736.3M
YoY Change 135.22% 986.61%
Cash & Equivalents $732.8M $736.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.797B $2.741B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.530B $3.477B
YoY Change 12.41% 12.72%
LONG-TERM ASSETS
Property, Plant & Equipment $91.28M $36.02M
YoY Change 143.77% 2.27%
Goodwill $16.40M $16.40M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $44.01M $44.87M
YoY Change -14.63% -13.22%
Other Assets $192.4M $225.2M
YoY Change -26.15% 16.34%
Total Long-Term Assets $492.5M $526.6M
YoY Change -14.32% 4.6%
TOTAL ASSETS
Total Short-Term Assets $3.530B $3.477B
Total Long-Term Assets $492.5M $526.6M
Total Assets $4.022B $4.003B
YoY Change 8.28% 11.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $204.7M $250.9M
YoY Change -10.46% -15.33%
Accrued Expenses $57.57M $59.40M
YoY Change -6.11% 5.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $262.2M $405.0M
YoY Change -31.53% -15.43%
LONG-TERM LIABILITIES
Long-Term Debt $859.6M $894.0M
YoY Change -8.38% 1.37%
Other Long-Term Liabilities $383.7M $278.6M
YoY Change 18.8% -32.98%
Total Long-Term Liabilities $1.243B $1.173B
YoY Change -1.42% -9.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $262.2M $405.0M
Total Long-Term Liabilities $1.243B $1.173B
Total Liabilities $1.506B $1.578B
YoY Change -8.44% -4.39%
SHAREHOLDERS EQUITY
Retained Earnings $2.301B $2.196B
YoY Change 25.35% 28.76%
Common Stock $350.2M $348.5M
YoY Change -0.77% -0.69%
Preferred Stock
YoY Change
Treasury Stock (at cost) $134.6M $118.8M
YoY Change 13.89% 0.11%
Treasury Stock Shares
Shareholders Equity $2.517B $2.426B
YoY Change
Total Liabilities & Shareholders Equity $4.022B $4.003B
YoY Change 8.28% 11.58%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $105.3M $139.0M
YoY Change -19.26% 5.64%
Depreciation, Depletion And Amortization $3.594M $3.600M
YoY Change -3.26% -2.86%
Cash From Operating Activities $54.93M $79.50M
YoY Change -72.29% -185.77%
INVESTING ACTIVITIES
Capital Expenditures $1.169M $2.500M
YoY Change -78.57% -310.97%
Acquisitions
YoY Change
Other Investing Activities -$3.363M -$8.800M
YoY Change 18.96% 36.43%
Cash From Investing Activities -$4.532M -$11.30M
YoY Change -45.28% 48.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -53.84M -300.0K
YoY Change -199.99% -98.55%
NET CHANGE
Cash From Operating Activities 54.93M 79.50M
Cash From Investing Activities -4.532M -11.30M
Cash From Financing Activities -53.84M -300.0K
Net Change In Cash -3.438M 67.90M
YoY Change -101.41% -156.12%
FREE CASH FLOW
Cash From Operating Activities $54.93M $79.50M
Capital Expenditures $1.169M $2.500M
Free Cash Flow $53.76M $77.00M
YoY Change -72.11% -184.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Interest Expense
InterestExpense
701000 usd
us-gaap Interest Expense
InterestExpense
2065000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1400000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1200000 usd
CY2023Q3 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 rate
CY2022Q3 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 rate
mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 rate
mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 rate
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1937773000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1624184000 usd
us-gaap Profit Loss
ProfitLoss
360267000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1002000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6613000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
55334000 usd
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
1041000 usd
us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
0 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1937773000 usd
us-gaap Net Income Loss
NetIncomeLoss
360083000 usd
us-gaap Net Income Loss
NetIncomeLoss
360267000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1588199000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1482628000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1622683000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1567685000 usd
mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
874000 usd
mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
7271000 usd
mho Additions Of Servicing Asset
AdditionsOfServicingAsset
-4312000 usd
mho Additions Of Servicing Asset
AdditionsOfServicingAsset
-7090000 usd
us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
1269000 usd
us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
1137000 usd
us-gaap Depreciation
Depreciation
9565000 usd
us-gaap Depreciation
Depreciation
9754000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2056000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1933000 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
990000 usd
mho Loss On Sale Of Mortgage Servicing Rights
LossOnSaleOfMortgageServicingRights
418000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7006000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6613000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
533036000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
37400000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51821000 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
18504000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-807000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
21426000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14149000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3878000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2046000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
19726000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
17366000 usd
us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
10207000 usd
us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14132000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19098000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
238900000 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 usd
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
238900000 usd
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-45122000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4119000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55334000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
120000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1002000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-135360000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-168607000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67761000 usd
us-gaap Interest Paid Net
InterestPaidNet
8562000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
123118000 usd
mho Community Development District Infrastructure
CommunityDevelopmentDistrictInfrastructure
11902000 usd
mho Consolidated Inventory Not Owned Obligation
ConsolidatedInventoryNotOwnedObligation
2010000 usd
mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
20758000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Unaudited Condensed Consolidated Financial Statements (the “financial statements”) of M/I Homes, Inc. and its subsidiaries (the “Company”) and notes thereto have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. The financial statements include the accounts of the Company. All intercompany transactions have been eliminated. Results for the interim period are not necessarily indicative of results for a full year. In the opinion of management, the accompanying financial statements reflect all adjustments (all of which are normal and recurring in nature) necessary for a fair presentation of financial results for the interim periods presented. These financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that period. Actual results could differ from these estimates and have a significant impact on the financial condition and results of operations and cash flows. With regard to the Company, estimates and assumptions are inherent in calculations relating to valuation of inventory and investment in unconsolidated joint ventures, property and equipment depreciation, valuation of derivative financial instruments, accounts payable on inventory, accruals for costs to complete inventory, accruals for warranty claims, accruals for self-insured general liability claims, litigation, accruals for health care and workers’ compensation, accruals for guaranteed or indemnified loans, stock-based compensation expense, income taxes, and contingencies. Items that could have a significant impact on these estimates and assumptions include the risks and uncertainties listed in “Item 1A. Risk Factors” in Part I of our 2022 Form 10-K, as the same may be updated from time to time in our subsequent filings with the SEC. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations - Joint Venture Formations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2023-05”), which addresses the accounting for contributions made to a joint venture. The amendments in ASU 2023-05 require joint ventures to initially measure all contributions received upon formation at fair value. This update will be applied prospectively to all joint venture formations with a formation date on or after January 1, 2025. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to our significant accounting policies during the quarter ended September 30, 2023 as compared to those disclosed in our 2022 Form 10-K.</span></div>
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1294779000 usd
CY2022Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
3331000 usd
CY2022Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1366804000 usd
CY2022Q4 mho Model Home Accumulated Depreciation
ModelHomeAccumulatedDepreciation
10371000 usd
CY2022Q4 mho Inventory Model Homes And Furnishings
InventoryModelHomesAndFurnishings
61200000 usd
CY2022Q4 mho Community Development District
CommunityDevelopmentDistrict
29701000 usd
CY2022Q4 mho Land Purchase Deposits
LandPurchaseDeposits
55739000 usd
CY2022Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
17048000 usd
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
2828602000 usd
CY2023Q3 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
2021 homes
CY2023Q3 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
395100000 usd
CY2022Q4 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
1827
CY2022Q4 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
431700000 usd
CY2022Q4 mho Community Development District
CommunityDevelopmentDistrict
29700000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
26495000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
21546000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
29292000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
28560000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
51600000 usd
mho Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
-6700000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
19700000 usd
CY2022Q4 mho Companysinvestmentinjointdevelopmentorsimilaragreements
Companysinvestmentinjointdevelopmentorsimilaragreements
45900000 usd
CY2022Q4 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
5700000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
44900000 usd
CY2023Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
7564000 usd
CY2023Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
681000 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
787000 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
3382000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q3 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
613700000 usd
CY2022Q4 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
360400000 usd
CY2023Q3 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
5900000 usd
CY2022Q4 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
2400000 usd
CY2023Q3 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
1600000 usd
CY2022Q4 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
700000 usd
CY2023Q3 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
365000000 usd
CY2022Q4 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
390000000 usd
CY2023Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
200600000 usd
CY2022Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
245700000 usd
CY2023Q3 us-gaap Equity Restrictions
EquityRestrictions
788000000 usd
CY2022Q4 us-gaap Equity Restrictions
EquityRestrictions
661700000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33519000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
29970000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
32902000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
29728000 usd
CY2023Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5545000 usd
CY2022Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5373000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
16296000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
15479000 usd
CY2023Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
647000 usd
CY2022Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2342000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2347000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3520000 usd
CY2023Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6287000 usd
CY2022Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6807000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
18121000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
17849000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33424000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30878000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33424000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30878000 usd
CY2023Q3 mho Letters Of Credit And Bonds
LettersOfCreditAndBonds
417600000 usd
CY2023Q3 mho Outstanding Performance Bonds
OutstandingPerformanceBonds
332100000 usd
CY2023Q3 mho Performance Letters Of Credit Outstanding
PerformanceLettersOfCreditOutstanding
67500000 usd
CY2023Q3 mho Financial Letters Of Credit
FinancialLettersOfCredit
9900000 usd
CY2023Q3 mho Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Contracts
OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionContracts
9500000 usd
CY2023Q3 mho Financial Bonds
FinancialBonds
4800000 usd
CY2023Q3 mho Corporate Notes
CorporateNotes
3300000 usd
CY2023Q3 us-gaap Purchase Options Land
PurchaseOptionsLand
1040000000.00 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1400000 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1200000 usd
CY2023Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
1950000000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q3 mho Letters Of Credit Outstanding Under Credit Facility
LettersOfCreditOutstandingUnderCreditFacility
77400000 usd
CY2023Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
572600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
139016000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
131590000 usd
us-gaap Net Income Loss
NetIncomeLoss
360083000 usd
us-gaap Net Income Loss
NetIncomeLoss
360267000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27909000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27618000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27769000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28025000 shares
CY2023Q3 mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
638000 shares
CY2022Q3 mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
248000 shares
mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
552000 shares
mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
274000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
290000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
319000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
310000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
311000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28837000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28185000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28631000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28610000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.98
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.86
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.82
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.59
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
908000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
826000 shares
us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3100000 usd
us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
8400000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38900000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219 rate
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210 rate
CY2023Q3 mho Change In Tax Benefit From Energy Efficient Home Credits
ChangeInTaxBenefitFromEnergyEfficientHomeCredits
6200000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-3000000 usd
CY2023Q3 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-1600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
110800000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233 rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235 rate
mho Change In Tax Benefit From Energy Efficient Home Credits
ChangeInTaxBenefitFromEnergyEfficientHomeCredits
5300000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-4600000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-1300000 usd
CY2023Q3 us-gaap Revenues
Revenues
1046371000 usd
CY2022Q3 us-gaap Revenues
Revenues
1012928000 usd
us-gaap Revenues
Revenues
3060914000 usd
us-gaap Revenues
Revenues
2914393000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
172131000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
167295000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
457376000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
473065000 usd
CY2023Q3 mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
5834000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
701000 usd
mho Interest Income Net Of Interest Expense
InterestIncomeNetOfInterestExpense
11893000 usd
us-gaap Interest Expense
InterestExpense
2065000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
177964000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
166594000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
469303000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
471017000 usd
CY2023Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
49595000 usd
CY2023Q3 mho Inventory Segments
InventorySegments
2690933000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
44866000 usd
CY2023Q3 mho Other Combined Assets
OtherCombinedAssets
1217974000 usd
CY2023Q3 us-gaap Assets
Assets
4003368000 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
55739000 usd
CY2022Q4 mho Inventory Segments
InventorySegments
2772863000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
51554000 usd
CY2022Q4 mho Other Combined Assets
OtherCombinedAssets
834767000 usd
CY2022Q4 us-gaap Assets
Assets
3714923000 usd
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2022Q1 mho Stock Repurchase Program Authorized Amount Increasedecrease
StockRepurchaseProgramAuthorizedAmountIncreasedecrease
100000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
300000 shares
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25100000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
52900000 usd
CY2023Q3 us-gaap Revenues
Revenues
1046371000 usd
CY2022Q3 us-gaap Revenues
Revenues
1012928000 usd
us-gaap Revenues
Revenues
3060914000 usd
us-gaap Revenues
Revenues
2914393000 usd
CY2023Q3 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
7400000 usd
CY2022Q3 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
13800000 usd
us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
11500000 usd
us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
32100000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd

Files In Submission

Name View Source Status
mho-20230930_cal.xml Edgar Link unprocessable
mho-20230930_def.xml Edgar Link unprocessable
0000799292-23-000120-index-headers.html Edgar Link pending
0000799292-23-000120-index.html Edgar Link pending
0000799292-23-000120.txt Edgar Link pending
0000799292-23-000120-xbrl.zip Edgar Link pending
exhibit101firstamendment.htm Edgar Link pending
exhibit101firstamendment001.jpg Edgar Link pending
exhibit101firstamendment002.jpg Edgar Link pending
exhibit101firstamendment003.jpg Edgar Link pending
exhibit101firstamendment004.jpg Edgar Link pending
exhibit101firstamendment005.jpg Edgar Link pending
exhibit101firstamendment006.jpg Edgar Link pending
exhibit101firstamendment007.jpg Edgar Link pending
exhibit102masterrepurcha.htm Edgar Link pending
exhibit102masterrepurcha001.jpg Edgar Link pending
exhibit102masterrepurcha002.jpg Edgar Link pending
exhibit102masterrepurcha003.jpg Edgar Link pending
exhibit102masterrepurcha004.jpg Edgar Link pending
exhibit102masterrepurcha005.jpg Edgar Link pending
exhibit102masterrepurcha006.jpg Edgar Link pending
exhibit102masterrepurcha007.jpg Edgar Link pending
exhibit102masterrepurcha008.jpg Edgar Link pending
exhibit102masterrepurcha009.jpg Edgar Link pending
exhibit102masterrepurcha010.jpg Edgar Link pending
exhibit102masterrepurcha011.jpg Edgar Link pending
exhibit102masterrepurcha012.jpg Edgar Link pending
exhibit102masterrepurcha013.jpg Edgar Link pending
exhibit102masterrepurcha014.jpg Edgar Link pending
exhibit102masterrepurcha015.jpg Edgar Link pending
exhibit102masterrepurcha016.jpg Edgar Link pending
exhibit102masterrepurcha017.jpg Edgar Link pending
exhibit102masterrepurcha018.jpg Edgar Link pending
exhibit102masterrepurcha019.jpg Edgar Link pending
exhibit102masterrepurcha020.jpg Edgar Link pending
exhibit102masterrepurcha021.jpg Edgar Link pending
exhibit102masterrepurcha022.jpg Edgar Link pending
exhibit102masterrepurcha023.jpg Edgar Link pending
exhibit102masterrepurcha024.jpg Edgar Link pending
exhibit102masterrepurcha025.jpg Edgar Link pending
exhibit102masterrepurcha026.jpg Edgar Link pending
exhibit102masterrepurcha027.jpg Edgar Link pending
exhibit102masterrepurcha028.jpg Edgar Link pending
exhibit102masterrepurcha029.jpg Edgar Link pending
exhibit102masterrepurcha030.jpg Edgar Link pending
exhibit102masterrepurcha031.jpg Edgar Link pending
exhibit102masterrepurcha032.jpg Edgar Link pending
exhibit102masterrepurcha033.jpg Edgar Link pending
exhibit102masterrepurcha034.jpg Edgar Link pending
exhibit102masterrepurcha035.jpg Edgar Link pending
exhibit102masterrepurcha036.jpg Edgar Link pending
exhibit102masterrepurcha037.jpg Edgar Link pending
exhibit102masterrepurcha038.jpg Edgar Link pending
exhibit102masterrepurcha039.jpg Edgar Link pending
exhibit102masterrepurcha040.jpg Edgar Link pending
exhibit102masterrepurcha041.jpg Edgar Link pending
exhibit102masterrepurcha042.jpg Edgar Link pending
exhibit102masterrepurcha043.jpg Edgar Link pending
exhibit102masterrepurcha044.jpg Edgar Link pending
exhibit102masterrepurcha045.jpg Edgar Link pending
exhibit102masterrepurcha046.jpg Edgar Link pending
exhibit102masterrepurcha047.jpg Edgar Link pending
exhibit102masterrepurcha048.jpg Edgar Link pending
exhibit102masterrepurcha049.jpg Edgar Link pending
exhibit102masterrepurcha050.jpg Edgar Link pending
exhibit102masterrepurcha051.jpg Edgar Link pending
exhibit102masterrepurcha052.jpg Edgar Link pending
exhibit102masterrepurcha053.jpg Edgar Link pending
exhibit102masterrepurcha054.jpg Edgar Link pending
exhibit102masterrepurcha055.jpg Edgar Link pending
exhibit102masterrepurcha056.jpg Edgar Link pending
exhibit102masterrepurcha057.jpg Edgar Link pending
exhibit102masterrepurcha058.jpg Edgar Link pending
exhibit102masterrepurcha059.jpg Edgar Link pending
exhibit102masterrepurcha060.jpg Edgar Link pending
exhibit102masterrepurcha061.jpg Edgar Link pending
exhibit102masterrepurcha062.jpg Edgar Link pending
exhibit102masterrepurcha063.jpg Edgar Link pending
exhibit102masterrepurcha064.jpg Edgar Link pending
exhibit102masterrepurcha065.jpg Edgar Link pending
exhibit102masterrepurcha066.jpg Edgar Link pending
exhibit102masterrepurcha067.jpg Edgar Link pending
exhibit102masterrepurcha068.jpg Edgar Link pending
exhibit102masterrepurcha069.jpg Edgar Link pending
exhibit102masterrepurcha070.jpg Edgar Link pending
exhibit102masterrepurcha071.jpg Edgar Link pending
exhibit102masterrepurcha072.jpg Edgar Link pending
exhibit102masterrepurcha073.jpg Edgar Link pending
exhibit102masterrepurcha074.jpg Edgar Link pending
exhibit102masterrepurcha075.jpg Edgar Link pending
exhibit102masterrepurcha076.jpg Edgar Link pending
exhibit102masterrepurcha077.jpg Edgar Link pending
exhibit102masterrepurcha078.jpg Edgar Link pending
exhibit102masterrepurcha079.jpg Edgar Link pending
exhibit102masterrepurcha080.jpg Edgar Link pending
exhibit102masterrepurcha081.jpg Edgar Link pending
exhibit102masterrepurcha082.jpg Edgar Link pending
exhibit102masterrepurcha083.jpg Edgar Link pending
exhibit102masterrepurcha084.jpg Edgar Link pending
exhibit102masterrepurcha085.jpg Edgar Link pending
exhibit102masterrepurcha086.jpg Edgar Link pending
exhibit102masterrepurcha087.jpg Edgar Link pending
exhibit102masterrepurcha088.jpg Edgar Link pending
exhibit102masterrepurcha089.jpg Edgar Link pending
exhibit102masterrepurcha090.jpg Edgar Link pending
exhibit102masterrepurcha091.jpg Edgar Link pending
exhibit102masterrepurcha092.jpg Edgar Link pending
exhibit102masterrepurcha093.jpg Edgar Link pending
exhibit102masterrepurcha094.jpg Edgar Link pending
exhibit102masterrepurcha095.jpg Edgar Link pending
exhibit102masterrepurcha096.jpg Edgar Link pending
exhibit102masterrepurcha097.jpg Edgar Link pending
exhibit102masterrepurcha098.jpg Edgar Link pending
exhibit102masterrepurcha099.jpg Edgar Link pending
exhibit102masterrepurcha100.jpg Edgar Link pending
exhibit102masterrepurcha101.jpg Edgar Link pending
exhibit102masterrepurcha102.jpg Edgar Link pending
exhibit102masterrepurcha103.jpg Edgar Link pending
exhibit102masterrepurcha104.jpg Edgar Link pending
exhibit102masterrepurcha105.jpg Edgar Link pending
exhibit102masterrepurcha106.jpg Edgar Link pending
exhibit102masterrepurcha107.jpg Edgar Link pending
exhibit102masterrepurcha108.jpg Edgar Link pending
exhibit102masterrepurcha109.jpg Edgar Link pending
exhibit102masterrepurcha110.jpg Edgar Link pending
exhibit102masterrepurcha111.jpg Edgar Link pending
exhibit102masterrepurcha112.jpg Edgar Link pending
exhibit102masterrepurcha113.jpg Edgar Link pending
exhibit102masterrepurcha114.jpg Edgar Link pending
exhibit102masterrepurcha115.jpg Edgar Link pending
exhibit102masterrepurcha116.jpg Edgar Link pending
exhibit102masterrepurcha117.jpg Edgar Link pending
exhibit102masterrepurcha118.jpg Edgar Link pending
exhibit102masterrepurcha119.jpg Edgar Link pending
exhibit102masterrepurcha120.jpg Edgar Link pending
exhibit102masterrepurcha121.jpg Edgar Link pending
exhibit102masterrepurcha122.jpg Edgar Link pending
exhibit102masterrepurcha123.jpg Edgar Link pending
exhibit102masterrepurcha124.jpg Edgar Link pending
exhibit102masterrepurcha125.jpg Edgar Link pending
exhibit102masterrepurcha126.jpg Edgar Link pending
exhibit102masterrepurcha127.jpg Edgar Link pending
exhibit102masterrepurcha128.jpg Edgar Link pending
exhibit102masterrepurcha129.jpg Edgar Link pending
exhibit102masterrepurcha130.jpg Edgar Link pending
exhibit102masterrepurcha131.jpg Edgar Link pending
exhibit102masterrepurcha132.jpg Edgar Link pending
exhibit102masterrepurcha133.jpg Edgar Link pending
exhibit102masterrepurcha134.jpg Edgar Link pending
exhibit102masterrepurcha135.jpg Edgar Link pending
exhibit102masterrepurcha136.jpg Edgar Link pending
exhibit102masterrepurcha137.jpg Edgar Link pending
exhibit102masterrepurcha138.jpg Edgar Link pending
exhibit102masterrepurcha139.jpg Edgar Link pending
exhibit102masterrepurcha140.jpg Edgar Link pending
exhibit102masterrepurcha141.jpg Edgar Link pending
exhibit102masterrepurcha142.jpg Edgar Link pending
exhibit102masterrepurcha143.jpg Edgar Link pending
exhibit102masterrepurcha144.jpg Edgar Link pending
exhibit102masterrepurcha145.jpg Edgar Link pending
exhibit102masterrepurcha146.jpg Edgar Link pending
exhibit102masterrepurcha147.jpg Edgar Link pending
exhibit102masterrepurcha148.jpg Edgar Link pending
exhibit102masterrepurcha149.jpg Edgar Link pending
exhibit102masterrepurcha150.jpg Edgar Link pending
exhibit102masterrepurcha151.jpg Edgar Link pending
exhibit102masterrepurcha152.jpg Edgar Link pending
exhibit102masterrepurcha153.jpg Edgar Link pending
exhibit102masterrepurcha154.jpg Edgar Link pending
exhibit102masterrepurcha155.jpg Edgar Link pending
exhibit102masterrepurcha156.jpg Edgar Link pending
exhibit102masterrepurcha157.jpg Edgar Link pending
exhibit102masterrepurcha158.jpg Edgar Link pending
exhibit102masterrepurcha159.jpg Edgar Link pending
exhibit102masterrepurcha160.jpg Edgar Link pending
exhibit102masterrepurcha161.jpg Edgar Link pending
exhibit102masterrepurcha162.jpg Edgar Link pending
exhibit102masterrepurcha163.jpg Edgar Link pending
exhibit102masterrepurcha164.jpg Edgar Link pending
exhibit102masterrepurcha165.jpg Edgar Link pending
exhibit102masterrepurcha166.jpg Edgar Link pending
exhibit102masterrepurcha167.jpg Edgar Link pending
exhibit102masterrepurcha168.jpg Edgar Link pending
exhibit102masterrepurcha169.jpg Edgar Link pending
exhibit102masterrepurcha170.jpg Edgar Link pending
exhibit102masterrepurcha171.jpg Edgar Link pending
exhibit102masterrepurcha172.jpg Edgar Link pending
exhibit102masterrepurcha173.jpg Edgar Link pending
exhibit102masterrepurcha174.jpg Edgar Link pending
exhibit102masterrepurcha175.jpg Edgar Link pending
exhibit102masterrepurcha176.jpg Edgar Link pending
exhibit102masterrepurcha177.jpg Edgar Link pending
exhibit102masterrepurcha178.jpg Edgar Link pending
exhibit102masterrepurcha179.jpg Edgar Link pending
exhibit102masterrepurcha180.jpg Edgar Link pending
exhibit102masterrepurcha181.jpg Edgar Link pending
exhibit102masterrepurcha182.jpg Edgar Link pending
exhibit102masterrepurcha183.jpg Edgar Link pending
exhibit102masterrepurcha184.jpg Edgar Link pending
exhibit102masterrepurcha185.jpg Edgar Link pending
exhibit102masterrepurcha186.jpg Edgar Link pending
exhibit102masterrepurcha187.jpg Edgar Link pending
exhibit102masterrepurcha188.jpg Edgar Link pending
exhibit102masterrepurcha189.jpg Edgar Link pending
exhibit102masterrepurcha190.jpg Edgar Link pending
exhibit102masterrepurcha191.jpg Edgar Link pending
exhibit102masterrepurcha192.jpg Edgar Link pending
exhibit102masterrepurcha193.jpg Edgar Link pending
exhibit102masterrepurcha194.jpg Edgar Link pending
exhibit102masterrepurcha195.jpg Edgar Link pending
exhibit102masterrepurcha196.jpg Edgar Link pending
exhibit102masterrepurcha197.jpg Edgar Link pending
exhibit102masterrepurcha198.jpg Edgar Link pending
exhibit102masterrepurcha199.jpg Edgar Link pending
exhibit102masterrepurcha200.jpg Edgar Link pending
exhibit102masterrepurcha201.jpg Edgar Link pending
exhibit102masterrepurcha202.jpg Edgar Link pending
exhibit102masterrepurcha203.jpg Edgar Link pending
exhibit102masterrepurcha204.jpg Edgar Link pending
exhibit102masterrepurcha205.jpg Edgar Link pending
exhibit102masterrepurcha206.jpg Edgar Link pending
exhibit22guarantors9-30x20.htm Edgar Link pending
exhibit311ceocertification.htm Edgar Link pending
exhibit312cfocertification.htm Edgar Link pending
exhibit321ceocertification.htm Edgar Link pending
exhibit322cfocertification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mho-20230930.htm Edgar Link pending
mho-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
mho-20230930_pre.xml Edgar Link unprocessable
mho-20230930_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mho-20230930_lab.xml Edgar Link unprocessable